Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference86 articles.
1. Foulkes W, Smith I, Reis-Filho J. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.
2. Cardoso F. Global Status Metastatic Breast Cancer Report (2005–2015). Glob status metastatic breast cancer rep. 2016. http://www.breastcancervision.com.
3. Waks AG, Winer EP, Winer M. Breast cancer treatment: a review. JAMA. 2019;321:288–300.
4. Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, José Godes Sanz de Bremond M, García González C, Torres, et al. Update on systemic treatment in early triple negative breast cancer. Ther Adv Med Oncol. 2021;13:1–18. https://doi.org/10.1177/1758835920986749.
5. Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382:810–21. https://www.nejm.org/doi/full/10.1056/NEJMoa1910549.